Table of Content

1 CD147 Antibody Market Overview
1.1 Product Overview and Scope of CD147 Antibody
1.2 CD147 Antibody Segment by Type
1.2.1 Global CD147 Antibody Market Value Comparison by Type (2023-2033)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 CD147 Antibody Segment by Application
1.3.1 Global CD147 Antibody Market Value by Application: (2023-2033)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Global CD147 Antibody Market Size Estimates and Forecasts
1.4.1 Global CD147 Antibody Revenue 2018-2033
1.4.2 Global CD147 Antibody Sales 2018-2033
1.4.3 Global CD147 Antibody Market Average Price (2018-2033)
1.5 Assumptions and Limitations
2 CD147 Antibody Market Competition by Manufacturers
2.1 Global CD147 Antibody Sales Market Share by Manufacturers (2018-2023)
2.2 Global CD147 Antibody Revenue Market Share by Manufacturers (2018-2023)
2.3 Global CD147 Antibody Average Price by Manufacturers (2018-2023)
2.4 Global CD147 Antibody Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of CD147 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD147 Antibody, Product Type & Application
2.7 CD147 Antibody Market Competitive Situation and Trends
2.7.1 CD147 Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest CD147 Antibody Players Market Share by Revenue
2.7.3 Global CD147 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CD147 Antibody Retrospective Market Scenario by Region
3.1 Global CD147 Antibody Market Size by Region: 2018 Versus 2022 Versus 2033
3.2 Global CD147 Antibody Global CD147 Antibody Sales by Region: 2018-2033
3.2.1 Global CD147 Antibody Sales by Region: 2018-2023
3.2.2 Global CD147 Antibody Sales by Region: 2024-2033
3.3 Global CD147 Antibody Global CD147 Antibody Revenue by Region: 2018-2033
3.3.1 Global CD147 Antibody Revenue by Region: 2018-2023
3.3.2 Global CD147 Antibody Revenue by Region: 2024-2033
3.4 North America CD147 Antibody Market Facts & Figures by Country
3.4.1 North America CD147 Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.4.2 North America CD147 Antibody Sales by Country (2018-2033)
3.4.3 North America CD147 Antibody Revenue by Country (2018-2033)
3.4.4 United States
3.4.5 Canada
3.5 Europe CD147 Antibody Market Facts & Figures by Country
3.5.1 Europe CD147 Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.5.2 Europe CD147 Antibody Sales by Country (2018-2033)
3.5.3 Europe CD147 Antibody Revenue by Country (2018-2033)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD147 Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific CD147 Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.6.2 Asia Pacific CD147 Antibody Sales by Country (2018-2033)
3.6.3 Asia Pacific CD147 Antibody Revenue by Country (2018-2033)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CD147 Antibody Market Facts & Figures by Country
3.7.1 Latin America CD147 Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.7.2 Latin America CD147 Antibody Sales by Country (2018-2033)
3.7.3 Latin America CD147 Antibody Revenue by Country (2018-2033)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa CD147 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa CD147 Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.8.2 Middle East and Africa CD147 Antibody Sales by Country (2018-2033)
3.8.3 Middle East and Africa CD147 Antibody Revenue by Country (2018-2033)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD147 Antibody Sales by Type (2018-2033)
4.1.1 Global CD147 Antibody Sales by Type (2018-2023)
4.1.2 Global CD147 Antibody Sales by Type (2024-2033)
4.1.3 Global CD147 Antibody Sales Market Share by Type (2018-2033)
4.2 Global CD147 Antibody Revenue by Type (2018-2033)
4.2.1 Global CD147 Antibody Revenue by Type (2018-2023)
4.2.2 Global CD147 Antibody Revenue by Type (2024-2033)
4.2.3 Global CD147 Antibody Revenue Market Share by Type (2018-2033)
4.3 Global CD147 Antibody Price by Type (2018-2033)
5 Segment by Application
5.1 Global CD147 Antibody Sales by Application (2018-2033)
5.1.1 Global CD147 Antibody Sales by Application (2018-2023)
5.1.2 Global CD147 Antibody Sales by Application (2024-2033)
5.1.3 Global CD147 Antibody Sales Market Share by Application (2018-2033)
5.2 Global CD147 Antibody Revenue by Application (2018-2033)
5.2.1 Global CD147 Antibody Revenue by Application (2018-2023)
5.2.2 Global CD147 Antibody Revenue by Application (2024-2033)
5.2.3 Global CD147 Antibody Revenue Market Share by Application (2018-2033)
5.3 Global CD147 Antibody Price by Application (2018-2033)
6 Key Companies Profiled
6.1 BosterBio
6.1.1 BosterBio Corporation Information
6.1.2 BosterBio Description and Business Overview
6.1.3 BosterBio CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.1.4 BosterBio CD147 Antibody Product Portfolio
6.1.5 BosterBio Recent Developments/Updates
6.2 Bioss
6.2.1 Bioss Corporation Information
6.2.2 Bioss Description and Business Overview
6.2.3 Bioss CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bioss CD147 Antibody Product Portfolio
6.2.5 Bioss Recent Developments/Updates
6.3 BD Biosciences
6.3.1 BD Biosciences Corporation Information
6.3.2 BD Biosciences Description and Business Overview
6.3.3 BD Biosciences CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BD Biosciences CD147 Antibody Product Portfolio
6.3.5 BD Biosciences Recent Developments/Updates
6.4 GeneTex
6.4.1 GeneTex Corporation Information
6.4.2 GeneTex Description and Business Overview
6.4.3 GeneTex CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GeneTex CD147 Antibody Product Portfolio
6.4.5 GeneTex Recent Developments/Updates
6.5 RayBiotech
6.5.1 RayBiotech Corporation Information
6.5.2 RayBiotech Description and Business Overview
6.5.3 RayBiotech CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.5.4 RayBiotech CD147 Antibody Product Portfolio
6.5.5 RayBiotech Recent Developments/Updates
6.6 Bio-Rad
6.6.1 Bio-Rad Corporation Information
6.6.2 Bio-Rad Description and Business Overview
6.6.3 Bio-Rad CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bio-Rad CD147 Antibody Product Portfolio
6.6.5 Bio-Rad Recent Developments/Updates
6.7 NSJ Bioreagents
6.6.1 NSJ Bioreagents Corporation Information
6.6.2 NSJ Bioreagents Description and Business Overview
6.6.3 NSJ Bioreagents CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 NSJ Bioreagents CD147 Antibody Product Portfolio
6.7.5 NSJ Bioreagents Recent Developments/Updates
6.8 BioLegend
6.8.1 BioLegend Corporation Information
6.8.2 BioLegend Description and Business Overview
6.8.3 BioLegend CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.8.4 BioLegend CD147 Antibody Product Portfolio
6.8.5 BioLegend Recent Developments/Updates
6.9 Abcam
6.9.1 Abcam Corporation Information
6.9.2 Abcam Description and Business Overview
6.9.3 Abcam CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Abcam CD147 Antibody Product Portfolio
6.9.5 Abcam Recent Developments/Updates
6.10 Cell Sciences
6.10.1 Cell Sciences Corporation Information
6.10.2 Cell Sciences Description and Business Overview
6.10.3 Cell Sciences CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Cell Sciences CD147 Antibody Product Portfolio
6.10.5 Cell Sciences Recent Developments/Updates
6.11 LifeSpan BioSciences
6.11.1 LifeSpan BioSciences Corporation Information
6.11.2 LifeSpan BioSciences CD147 Antibody Description and Business Overview
6.11.3 LifeSpan BioSciences CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.11.4 LifeSpan BioSciences CD147 Antibody Product Portfolio
6.11.5 LifeSpan BioSciences Recent Developments/Updates
6.12 Bethyl Laboratories
6.12.1 Bethyl Laboratories Corporation Information
6.12.2 Bethyl Laboratories CD147 Antibody Description and Business Overview
6.12.3 Bethyl Laboratories CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Bethyl Laboratories CD147 Antibody Product Portfolio
6.12.5 Bethyl Laboratories Recent Developments/Updates
6.13 HUABIO
6.13.1 HUABIO Corporation Information
6.13.2 HUABIO CD147 Antibody Description and Business Overview
6.13.3 HUABIO CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.13.4 HUABIO CD147 Antibody Product Portfolio
6.13.5 HUABIO Recent Developments/Updates
6.14 Thermo Fisher Scientific
6.14.1 Thermo Fisher Scientific Corporation Information
6.14.2 Thermo Fisher Scientific CD147 Antibody Description and Business Overview
6.14.3 Thermo Fisher Scientific CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Thermo Fisher Scientific CD147 Antibody Product Portfolio
6.14.5 Thermo Fisher Scientific Recent Developments/Updates
6.15 Novus Biologicals
6.15.1 Novus Biologicals Corporation Information
6.15.2 Novus Biologicals CD147 Antibody Description and Business Overview
6.15.3 Novus Biologicals CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Novus Biologicals CD147 Antibody Product Portfolio
6.15.5 Novus Biologicals Recent Developments/Updates
6.16 Elabscience Biotechnology
6.16.1 Elabscience Biotechnology Corporation Information
6.16.2 Elabscience Biotechnology CD147 Antibody Description and Business Overview
6.16.3 Elabscience Biotechnology CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Elabscience Biotechnology CD147 Antibody Product Portfolio
6.16.5 Elabscience Biotechnology Recent Developments/Updates
6.17 R&D Systems
6.17.1 R&D Systems Corporation Information
6.17.2 R&D Systems CD147 Antibody Description and Business Overview
6.17.3 R&D Systems CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.17.4 R&D Systems CD147 Antibody Product Portfolio
6.17.5 R&D Systems Recent Developments/Updates
6.18 Miltenyi Biotec
6.18.1 Miltenyi Biotec Corporation Information
6.18.2 Miltenyi Biotec CD147 Antibody Description and Business Overview
6.18.3 Miltenyi Biotec CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Miltenyi Biotec CD147 Antibody Product Portfolio
6.18.5 Miltenyi Biotec Recent Developments/Updates
6.19 Biobyt
6.19.1 Biobyt Corporation Information
6.19.2 Biobyt CD147 Antibody Description and Business Overview
6.19.3 Biobyt CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Biobyt CD147 Antibody Product Portfolio
6.19.5 Biobyt Recent Developments/Updates
6.20 Jingjie PTM BioLab
6.20.1 Jingjie PTM BioLab Corporation Information
6.20.2 Jingjie PTM BioLab CD147 Antibody Description and Business Overview
6.20.3 Jingjie PTM BioLab CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Jingjie PTM BioLab CD147 Antibody Product Portfolio
6.20.5 Jingjie PTM BioLab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD147 Antibody Industry Chain Analysis
7.2 CD147 Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD147 Antibody Production Mode & Process
7.4 CD147 Antibody Sales and Marketing
7.4.1 CD147 Antibody Sales Channels
7.4.2 CD147 Antibody Distributors
7.5 CD147 Antibody Customers
8 CD147 Antibody Market Dynamics
8.1 CD147 Antibody Industry Trends
8.2 CD147 Antibody Market Drivers
8.3 CD147 Antibody Market Challenges
8.4 CD147 Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global CD147 Antibody Market Value Comparison by Type (2023-2033) & (US$ Million)
Table 2. Global CD147 Antibody Market Value Comparison by Application (2023-2033) & (US$ Million)
Table 3. Global CD147 Antibody Market Competitive Situation by Manufacturers in 2022
Table 4. Global CD147 Antibody Sales (ml) of Key Manufacturers (2018-2023)
Table 5. Global CD147 Antibody Sales Market Share by Manufacturers (2018-2023)
Table 6. Global CD147 Antibody Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global CD147 Antibody Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market CD147 Antibody Average Price (US$/ml) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of CD147 Antibody, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of CD147 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CD147 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of CD147 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD147 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD147 Antibody as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CD147 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 17. Global CD147 Antibody Sales by Region (2018-2023) & (ml)
Table 18. Global CD147 Antibody Sales Market Share by Region (2018-2023)
Table 19. Global CD147 Antibody Sales by Region (2024-2033) & (ml)
Table 20. Global CD147 Antibody Sales Market Share by Region (2024-2033)
Table 21. Global CD147 Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global CD147 Antibody Revenue Market Share by Region (2018-2023)
Table 23. Global CD147 Antibody Revenue by Region (2024-2033) & (US$ Million)
Table 24. Global CD147 Antibody Revenue Market Share by Region (2024-2033)
Table 25. North America CD147 Antibody Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 26. North America CD147 Antibody Sales by Country (2018-2023) & (ml)
Table 27. North America CD147 Antibody Sales by Country (2024-2033) & (ml)
Table 28. North America CD147 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America CD147 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 30. Europe CD147 Antibody Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 31. Europe CD147 Antibody Sales by Country (2018-2023) & (ml)
Table 32. Europe CD147 Antibody Sales by Country (2024-2033) & (ml)
Table 33. Europe CD147 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe CD147 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 35. Asia Pacific CD147 Antibody Revenue by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 36. Asia Pacific CD147 Antibody Sales by Region (2018-2023) & (ml)
Table 37. Asia Pacific CD147 Antibody Sales by Region (2024-2033) & (ml)
Table 38. Asia Pacific CD147 Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific CD147 Antibody Revenue by Region (2024-2033) & (US$ Million)
Table 40. Latin America CD147 Antibody Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 41. Latin America CD147 Antibody Sales by Country (2018-2023) & (ml)
Table 42. Latin America CD147 Antibody Sales by Country (2024-2033) & (ml)
Table 43. Latin America CD147 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America CD147 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa CD147 Antibody Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 46. Middle East & Africa CD147 Antibody Sales by Country (2018-2023) & (ml)
Table 47. Middle East & Africa CD147 Antibody Sales by Country (2024-2033) & (ml)
Table 48. Middle East & Africa CD147 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa CD147 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 50. Global CD147 Antibody Sales (ml) by Type (2018-2023)
Table 51. Global CD147 Antibody Sales (ml) by Type (2024-2033)
Table 52. Global CD147 Antibody Sales Market Share by Type (2018-2023)
Table 53. Global CD147 Antibody Sales Market Share by Type (2024-2033)
Table 54. Global CD147 Antibody Revenue (US$ Million) by Type (2018-2023)
Table 55. Global CD147 Antibody Revenue (US$ Million) by Type (2024-2033)
Table 56. Global CD147 Antibody Revenue Market Share by Type (2018-2023)
Table 57. Global CD147 Antibody Revenue Market Share by Type (2024-2033)
Table 58. Global CD147 Antibody Price (US$/ml) by Type (2018-2023)
Table 59. Global CD147 Antibody Price (US$/ml) by Type (2024-2033)
Table 60. Global CD147 Antibody Sales (ml) by Application (2018-2023)
Table 61. Global CD147 Antibody Sales (ml) by Application (2024-2033)
Table 62. Global CD147 Antibody Sales Market Share by Application (2018-2023)
Table 63. Global CD147 Antibody Sales Market Share by Application (2024-2033)
Table 64. Global CD147 Antibody Revenue (US$ Million) by Application (2018-2023)
Table 65. Global CD147 Antibody Revenue (US$ Million) by Application (2024-2033)
Table 66. Global CD147 Antibody Revenue Market Share by Application (2018-2023)
Table 67. Global CD147 Antibody Revenue Market Share by Application (2024-2033)
Table 68. Global CD147 Antibody Price (US$/ml) by Application (2018-2023)
Table 69. Global CD147 Antibody Price (US$/ml) by Application (2024-2033)
Table 70. BosterBio Corporation Information
Table 71. BosterBio Description and Business Overview
Table 72. BosterBio CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 73. BosterBio CD147 Antibody Product
Table 74. BosterBio Recent Developments/Updates
Table 75. Bioss Corporation Information
Table 76. Bioss Description and Business Overview
Table 77. Bioss CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 78. Bioss CD147 Antibody Product
Table 79. Bioss Recent Developments/Updates
Table 80. BD Biosciences Corporation Information
Table 81. BD Biosciences Description and Business Overview
Table 82. BD Biosciences CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 83. BD Biosciences CD147 Antibody Product
Table 84. BD Biosciences Recent Developments/Updates
Table 85. GeneTex Corporation Information
Table 86. GeneTex Description and Business Overview
Table 87. GeneTex CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 88. GeneTex CD147 Antibody Product
Table 89. GeneTex Recent Developments/Updates
Table 90. RayBiotech Corporation Information
Table 91. RayBiotech Description and Business Overview
Table 92. RayBiotech CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 93. RayBiotech CD147 Antibody Product
Table 94. RayBiotech Recent Developments/Updates
Table 95. Bio-Rad Corporation Information
Table 96. Bio-Rad Description and Business Overview
Table 97. Bio-Rad CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 98. Bio-Rad CD147 Antibody Product
Table 99. Bio-Rad Recent Developments/Updates
Table 100. NSJ Bioreagents Corporation Information
Table 101. NSJ Bioreagents Description and Business Overview
Table 102. NSJ Bioreagents CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 103. NSJ Bioreagents CD147 Antibody Product
Table 104. NSJ Bioreagents Recent Developments/Updates
Table 105. BioLegend Corporation Information
Table 106. BioLegend Description and Business Overview
Table 107. BioLegend CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 108. BioLegend CD147 Antibody Product
Table 109. BioLegend Recent Developments/Updates
Table 110. Abcam Corporation Information
Table 111. Abcam Description and Business Overview
Table 112. Abcam CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 113. Abcam CD147 Antibody Product
Table 114. Abcam Recent Developments/Updates
Table 115. Cell Sciences Corporation Information
Table 116. Cell Sciences Description and Business Overview
Table 117. Cell Sciences CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 118. Cell Sciences CD147 Antibody Product
Table 119. Cell Sciences Recent Developments/Updates
Table 120. LifeSpan BioSciences Corporation Information
Table 121. LifeSpan BioSciences Description and Business Overview
Table 122. LifeSpan BioSciences CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 123. LifeSpan BioSciences CD147 Antibody Product
Table 124. LifeSpan BioSciences Recent Developments/Updates
Table 125. Bethyl Laboratories Corporation Information
Table 126. Bethyl Laboratories Description and Business Overview
Table 127. Bethyl Laboratories CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 128. Bethyl Laboratories CD147 Antibody Product
Table 129. Bethyl Laboratories Recent Developments/Updates
Table 130. HUABIO Corporation Information
Table 131. HUABIO Description and Business Overview
Table 132. HUABIO CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 133. HUABIO CD147 Antibody Product
Table 134. HUABIO Recent Developments/Updates
Table 135. Thermo Fisher Scientific Corporation Information
Table 136. Thermo Fisher Scientific Description and Business Overview
Table 137. Thermo Fisher Scientific CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 138. Thermo Fisher Scientific CD147 Antibody Product
Table 139. Thermo Fisher Scientific Recent Developments/Updates
Table 140. Novus Biologicals Corporation Information
Table 141. Novus Biologicals Description and Business Overview
Table 142. Novus Biologicals CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 143. Novus Biologicals CD147 Antibody Product
Table 144. Novus Biologicals Recent Developments/Updates
Table 145. Elabscience Biotechnology Corporation Information
Table 146. Elabscience Biotechnology Description and Business Overview
Table 147. Elabscience Biotechnology CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 148. Elabscience Biotechnology CD147 Antibody Product
Table 149. Elabscience Biotechnology Recent Developments/Updates
Table 150. R&D Systems Corporation Information
Table 151. R&D Systems Description and Business Overview
Table 152. R&D Systems CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 153. R&D Systems CD147 Antibody Product
Table 154. R&D Systems Recent Developments/Updates
Table 155. Miltenyi Biotec Corporation Information
Table 156. Miltenyi Biotec Description and Business Overview
Table 157. Miltenyi Biotec CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 158. Miltenyi Biotec CD147 Antibody Product
Table 159. Miltenyi Biotec Recent Developments/Updates
Table 160. Biobyt Corporation Information
Table 161. Biobyt Description and Business Overview
Table 162. Biobyt CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 163. Biobyt CD147 Antibody Product
Table 164. Biobyt Recent Developments/Updates
Table 165. Jingjie PTM BioLab Corporation Information
Table 166. Jingjie PTM BioLab Description and Business Overview
Table 167. Jingjie PTM BioLab CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 168. Jingjie PTM BioLab CD147 Antibody Product
Table 169. Jingjie PTM BioLab Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. CD147 Antibody Distributors List
Table 173. CD147 Antibody Customers List
Table 174. CD147 Antibody Market Trends
Table 175. CD147 Antibody Market Drivers
Table 176. CD147 Antibody Market Challenges
Table 177. CD147 Antibody Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of CD147 Antibody
Figure 2. Global CD147 Antibody Market Value Comparison by Type (2023-2033) & (US$ Million)
Figure 3. Global CD147 Antibody Market Share by Type in 2022 & 2033
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global CD147 Antibody Market Value Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global CD147 Antibody Market Share by Application in 2022 & 2033
Figure 8. Immunochemistry (IHC)
Figure 9. Immunofluorescence (IF)
Figure 10. Immunoprecipitation (IP)
Figure 11. Western Blot (WB)
Figure 12. ELISA
Figure 13. Others
Figure 14. Global CD147 Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global CD147 Antibody Market Size (2018-2033) & (US$ Million)
Figure 16. Global CD147 Antibody Sales (2018-2033) & (ml)
Figure 17. Global CD147 Antibody Average Price (US$/ml) & (2018-2033)
Figure 18. CD147 Antibody Report Years Considered
Figure 19. CD147 Antibody Sales Share by Manufacturers in 2022
Figure 20. Global CD147 Antibody Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest CD147 Antibody Players: Market Share by Revenue in 2022
Figure 22. CD147 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global CD147 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Figure 24. North America CD147 Antibody Sales Market Share by Country (2018-2033)
Figure 25. North America CD147 Antibody Revenue Market Share by Country (2018-2033)
Figure 26. United States CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 27. Canada CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 28. Europe CD147 Antibody Sales Market Share by Country (2018-2033)
Figure 29. Europe CD147 Antibody Revenue Market Share by Country (2018-2033)
Figure 30. Germany CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 31. France CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 32. U.K. CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 33. Italy CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 34. Russia CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 35. Asia Pacific CD147 Antibody Sales Market Share by Region (2018-2033)
Figure 36. Asia Pacific CD147 Antibody Revenue Market Share by Region (2018-2033)
Figure 37. China CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 38. Japan CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 39. South Korea CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 40. India CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 41. Australia CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 42. China Taiwan CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 43. Southeast Asia CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 44. Latin America CD147 Antibody Sales Market Share by Country (2018-2033)
Figure 45. Latin America CD147 Antibody Revenue Market Share by Country (2018-2033)
Figure 46. Mexico CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 47. Brazil CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 48. Argentina CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 49. Colombia CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa CD147 Antibody Sales Market Share by Country (2018-2033)
Figure 51. Middle East & Africa CD147 Antibody Revenue Market Share by Country (2018-2033)
Figure 52. Turkey CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 54. UAE CD147 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 55. Global Sales Market Share of CD147 Antibody by Type (2018-2033)
Figure 56. Global Revenue Market Share of CD147 Antibody by Type (2018-2033)
Figure 57. Global CD147 Antibody Price (US$/ml) by Type (2018-2033)
Figure 58. Global Sales Market Share of CD147 Antibody by Application (2018-2033)
Figure 59. Global Revenue Market Share of CD147 Antibody by Application (2018-2033)
Figure 60. Global CD147 Antibody Price (US$/ml) by Application (2018-2033)
Figure 61. CD147 Antibody Value Chain
Figure 62. CD147 Antibody Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed